Extra-cardiac management of cardiogenic shock in the intensive care unit

IF 6.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Heart and Lung Transplantation Pub Date : 2024-05-30 DOI:10.1016/j.healun.2024.03.017
Varinder K. Randhawa MD PhD , Ran Lee MD , Carlos L. Alviar MD , Aniket S. Rali MD , Alexandra Arias MD , Anjali Vaidya MD , Emily K. Zern MD , Andrew Fagan MD MEd , Alastair G. Proudfoot MBChB PhD , Jason N. Katz MD MHS
{"title":"Extra-cardiac management of cardiogenic shock in the intensive care unit","authors":"Varinder K. Randhawa MD PhD ,&nbsp;Ran Lee MD ,&nbsp;Carlos L. Alviar MD ,&nbsp;Aniket S. Rali MD ,&nbsp;Alexandra Arias MD ,&nbsp;Anjali Vaidya MD ,&nbsp;Emily K. Zern MD ,&nbsp;Andrew Fagan MD MEd ,&nbsp;Alastair G. Proudfoot MBChB PhD ,&nbsp;Jason N. Katz MD MHS","doi":"10.1016/j.healun.2024.03.017","DOIUrl":null,"url":null,"abstract":"<div><p>Cardiogenic shock (CS) is a heterogeneous clinical syndrome characterized by low cardiac output leading to end-organ hypoperfusion. Organ dysoxia ranging from transient organ injury to irreversible organ failure and death occurs across all CS etiologies but differing by incidence and type. Herein, we review the recognition and management of respiratory, renal and hepatic failure complicating CS. We also discuss unmet needs in the CS care pathway and future research priorities for generating evidence-based best practices for the management of extra-cardiac sequelae. The complexity of CS admitted to the contemporary cardiac intensive care unit demands a workforce skilled to care for these extra-cardiac critical illness complications with an appreciation for how cardio-systemic interactions influence critical illness outcomes in afflicted patients.</p></div>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":null,"pages":null},"PeriodicalIF":6.4000,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart and Lung Transplantation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1053249824015596","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiogenic shock (CS) is a heterogeneous clinical syndrome characterized by low cardiac output leading to end-organ hypoperfusion. Organ dysoxia ranging from transient organ injury to irreversible organ failure and death occurs across all CS etiologies but differing by incidence and type. Herein, we review the recognition and management of respiratory, renal and hepatic failure complicating CS. We also discuss unmet needs in the CS care pathway and future research priorities for generating evidence-based best practices for the management of extra-cardiac sequelae. The complexity of CS admitted to the contemporary cardiac intensive care unit demands a workforce skilled to care for these extra-cardiac critical illness complications with an appreciation for how cardio-systemic interactions influence critical illness outcomes in afflicted patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症监护室心源性休克的心外治疗。
心源性休克(CS)是一种以低心排血量导致末梢器官灌注不足为特征的异质性临床综合征。从一过性器官损伤到不可逆器官衰竭和死亡的器官缺氧发生在所有 CS 病因中,但发生率和类型各不相同。在此,我们回顾了 CS 并发呼吸、肾和肝功能衰竭的识别和处理。我们还讨论了 CS 护理路径中尚未满足的需求,以及为管理心外后遗症制定循证最佳实践的未来研究重点。当代心脏重症监护病房收治的 CS 患者病情复杂,需要有一支能够熟练处理这些心外危重症并发症的医疗队伍,并了解心外系统的相互作用如何影响患者的危重症预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.10
自引率
6.70%
发文量
1667
审稿时长
69 days
期刊介绍: The Journal of Heart and Lung Transplantation, the official publication of the International Society for Heart and Lung Transplantation, brings readers essential scholarly and timely information in the field of cardio-pulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas.
期刊最新文献
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension. A Perspective on the Added Value of Red Blood Cells during Cardiac Hypothermic Oxygenated Perfusion. Loss of Nr4a1 ameliorates endothelial cell injury and vascular leakage in lung transplantation from circulatory-death donor. The Outcome of Restrictive Cardiac Allograft Physiology in Severe Coronary Allograft Vasculopathy. Defining direct and indirect right ventricular unloading.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1